NATIONAL BIO-BANK FOR IPF
The Stem Cell Therapy Unit continue to manage the National bio-bank for Idiopathic Pulmonary Fibrosis (IPF).
Researchers collect, process and store samples from IPF patients for an Australia-wide collection.
This biobank aims to enroll all Australians with IPF so that the data collected can help researchers learn more about this serious disorder and improve treatment options.
A/Prof Yuben Moodley is also collaborating with other research groups within the Institute:
- The Stem Cell Therapy and Molecular Genetics and Inflammation Units are are exploring the bio-markers for IPF. Using the samples collected in the IPF biobank, they are examining the protein and RNA signatures of the disease progression.
- The Stem Cell Therapy and Tissue Repair Group are researching the genetic analysis of IPF samples, with an aim of exploring the mechanisms in the development of IPF.
To get involved or for more information, contact the Research Leader.